Growth Metrics

Edwards Lifesciences (EW) Treasury Shares (2016 - 2026)

Edwards Lifesciences has reported Treasury Shares over the past 17 years, most recently at $7.1 billion for Q4 2025.

  • For Q4 2025, Treasury Shares rose 14.52% year-over-year to $7.1 billion; the TTM value through Dec 2025 reached $7.1 billion, up 14.52%, while the annual FY2025 figure was $7.1 billion, 14.52% up from the prior year.
  • Treasury Shares for Q4 2025 was $78.0 million at Edwards Lifesciences, up from $6.3 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $78.0 million in Q4 2025 and troughed at $100000.0 in Q2 2023.
  • A 5-year average of $37.7 million and a median of $39.6 million in 2022 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: skyrocketed 71.46% in 2022 and later rose 14.37% in 2024.
  • Year by year, Treasury Shares stood at $2.4 billion in 2021, then skyrocketed by 71.46% to $4.1 billion in 2022, then rose by 21.25% to $5.0 billion in 2023, then rose by 23.24% to $6.2 billion in 2024, then increased by 14.52% to $7.1 billion in 2025.
  • Business Quant data shows Treasury Shares for EW at $7.1 billion in Q4 2025, $7.0 billion in Q3 2025, and $6.5 billion in Q2 2025.